RxDoctor Payments Data

Michael Wolff, MD

Pain Medicine · Scottsdale, AZNPI 1376508697

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,374 of the $2,037 with a category attached, or 67.5%. 21 manufacturers reported payments, led by Stryker at 31.5% of the total. That places this record below the midpoint for pain medicine clinicians in AZ, where the typical reported total is $3,853.

$2,037in general payments, 2019–2025

Across 63 payments — averaging $32.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$641
  • Amgen$269
  • Vertex$137
  • Fidia Pharma USA Inc.$137
  • Abbott$126
  • Biodelivery Sciences International, Inc.$111
  • plus $616 from 15 others
$6,380in research payments, 2019–2025

Across 1 payment — averaging $6380.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arteriocyte Medical Systems, Inc.$6K

What the payments were for

  • Travel & lodging$64131%
  • Food & beverage$1,37467%
  • Education$211%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,037 in reported general payments places this provider in the 30th percentile of 180 pain medicine providers in Arizona.

See all pain medicine providers in Arizona →

Medicare billing

Part B allowed, 2024
$221,410
Medicare patients
475
Services billed
3,806

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib25$514
Gabapentin48$368
Tramadol Hcl51$179
Methylprednisolone27$174
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$150
Tizanidine Hcl15$68

Paid to pharmacies, not to this prescriber.

Other pain medicine in Scottsdale

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →